We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune ...

In a nutshell Same-arm booster shots trigger a stronger early immune response than shots given in the opposite arm, leading ...

Are you preparing for UPSC CSE Prelims 2025? Check your progress and revise your topics through this quiz on Science and ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

According to Towards Healthcare research, the global polyclonal antibodies market size is calculated at USD 1.76 billion in ...

After 40 years of donating to Canadian Blood Services, 18 years of volunteer firefighting in Collingwood, and 30 years of ...

Blood Grouping Reagents Market size, share, and forecast up to 2035, highlighting innovations in blood typing reagents and key growth drivers ...

Safi to bulk manufacture Children's Hospital of Philadelphia's iPSC-derived RBCs with rare antigen profiles as diagnostic tools for alloim ...

In a recent investor interview, Diamyd Medical Board Member Professor Mark Atkinson and CEO Ulf Hannelius shared key insights into the Company's positioning ...

In a recent investor interview, Diamyd Medical Board Member Professor Mark Atkinson and CEO Ulf Hannelius shared key insights into the Company's positioning as a first-mover in precision ...